INTERNATIONAL PATENT: ORICELL THERAPEUTICS CO., LTD., 原启生物科技（上海）有限责任公司 FILES APPLICATION FOR "HUMANIZED NANOBODY TARGETING BCMA AND USE THEREOF"

GENEVA, Feb. 8 -- ORICELL THERAPEUTICS CO., LTD. (3F, Bldg 1, No.1227 Zhangheng RoadPudong New Area, Shanghai 201203), 原启生物科技（上海）有限责任公司 (中国上海市浦东新区张衡路1227号1号楼3楼) filed a patent application (PCT/CN2025/112179) for "HUMANIZED NANOBODY TARGETING BCMA AND USE THEREOF" on Aug 01, 2025. With publication no. WO/2026/026960, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the ...